Published in Blood Weekly, December 17th, 2009
"These findings are significant because it is the first time a combination of specific chemicals has successfully destroyed diverse forms of amyloids...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.